Dr. Weisman has been quoted in a new article in The Philadelphia Inquirer regarding the dangers of 23andMe genetic testing. The FDA recently allowed 23andMe to start releasing health risk information to its customers, including an assessment of their risk of developing Alzheimer’s disease.
Weisman, who knows of two patients who killed themselves after getting an Alzheimer’s diagnosis, was so concerned about 23andMe’s decision to release information about APOE4 that he wrote to the FDA to urge it to change its “terrible decision.”
“This is a travesty,” he said in an interview. “The FDA has allowed this private company to release information and potentially drop bombshells into a family with really no control … or professionalism.”